Clinical case of membranous nephropathy in a patient with IgG4-related disease

IgG4-related disease (IgG4-RD) currently is considered as a chronic fibroinflammatory immune-mediated multisystemic condition of unidentified etiology, which can imitate a wide range of malignant, infectious, rheumatologic, and other diseases. It can affect almost any organ system in the body synchronously or sequentially, but the most often affected are the pancreas, hepatobiliary tract, periorbital structures, salivary glands, kidneys, and lymph nodes. The most frequent renal manifestations of IgG4-RD is IgG4-related tubulointerstitial nephritis. Membranous nephropathy is the most common glomerular disease accompanied by IgG4-RD. Regardless of the organ localization, patients with IgG4-RD are characterized by elevated serum IgG4, but this laboratory abnormality is not specific and can be changed in other diseases. In all suspected cases of IgG4-RD the diagnosis should be confirmed by histological examination. Characteristic pathologic features include diffuse or focal lymphoplasmacytic infiltration with prominent IgG4+ plasma cells, storiform fibrosis, and obliterative phlebitis. Patients with IgG4- RD usually have an excellent clinical response to glucocorticoids, but relapse rates after steroid withdrawal are high, which may require additional use of immunosuppressants or rituximab. Due to the low prevalence and multitude of clinical manifestations the disease often remains underdiagnosed on time. This case report describes middle-aged patients with a history of chronic recurrent pancreatitis complicated by the nephrotic syndrome. Kidney biopsy showed membranous nephropathy and diagnosis IgG4-RD with multiorgan involvement was made. Partial remission was achieved on corticosteroid therapy. The presented case clearly demonstrates the difficulties of diagnosis and treatment of IgG4-RD. IgG4-related membranous nephropathy should be included in the differential diagnosis for patients with nephrotic syndrome accompanied by multiorgan dysfunction.

1. Wolfson A, Hamilos D. Recent advances in understanding and managing IgG4-related disease. F1000Res 2017;23(6). pii: F1000 Faculty Rev-185. doi: 10.12688/f1000research.9399.1

2. Yamada K, Yamamoto M, Saeki T et al. New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases. Arthritis Research & Therapy 2017;19(1). doi: 10.1186/s13075-017-1467-x

3. Umehara H, Okazaki K, Masaki Y et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Modern Rheumatology 2012;22(1):21–30. doi: 10.1007/s10165-011-0571-z

4. Stone J, Khosroshahi A, Deshpande V et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis & Rheumatism 2012;64(10):3061–3067. doi: 10.1002/art.34593

5. Cornell L. IgG4-related kidney disease. Curr Opin Nephrol Hypertens 2012;21:279–288. doi: 10.1097/mnh.0b013e32835265ac

6. Zheng K, Teng F, Li X. Immunoglobulin G4-related kidney disease: Pathogenesis, diagnosis, and treatment. Chronic Diseases and Translational Medicine 2017;3(3):138–147. doi: 10.1016/j.cdtm.2017.05.003

7. Chen Y, Zhao J, Feng R et al. Types of Organ Involvement in Patients with Immunoglobulin G4-related Disease. Chin Med J (Engl) 2016;129(13):1525–1532. doi: 10.4103/0366-6999.184459

8. Martínez-Valle F, Fernández-Codina A, Pinal-Fernández I et al. IgG4-related disease: Evidence from six recent cohorts. Autoimmun Rev 2017;16(2):168–172. doi: 10.1016/j.autrev.2016.12.008

9. Inoue D, Yoshida K, Yoneda N et al. IgG4-Related Disease: Dataset of 235 Consecutive Patients. Medicine (Baltimore) 2015;94(15):e680. doi: 10.1097/md.0000000000000680

10. Bledsoe J, Della-Torre E, Rovati L et al. IgG4-related disease: review of the histopathologic features, differential diagnosis, and therapeutic approach. APMIS 2018;126(6):459–476. doi: 10.1111/apm.12845

11. Kawano M, Saeki T, Nakashima H. IgG4-related kidney disease and retroperitoneal fibrosis: An update. Modern Rheumatology 2019;29(2):231–239. doi: 10.1080/14397595.2018.1554321

12. Zhang P, Cornell L. IgG4-Related Tubulointerstitial Nephritis. Advances in Chronic Kidney Disease 2017;24(2):94–100. doi: 10.1053/j.ackd.2016.12.001

13. Raissian Y, Nasr SH, Larsen CP et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol 2011;22(7):1343–1352. doi: 10.1681/ASN.2011010062

14. Nishi S, Imai N, Yoshida K et al. Clinicopathological findings of immunoglobulin G4-related kidney disease. Clinical and Experimental Nephrology 2011;15(6):810–819. doi: 10.1007/s10157-011-0526-x

15. Kim B, Kim J, Byun J et al. IgG4-related kidney disease: MRI findings with emphasis on the usefulness of diffusion-weighted imaging. European Journal of Radiology 2014;83(7):1057–1062. doi: 10.1016/j.ejrad.2014.03.033

16. Masaki Y, Shimizu H, Sato Nakamura T et al. IgG4-related disease: diagnostic methods and therapeutic strategies in Japan. J Clin Exp Hematop 2014;54(2):95–101. doi:10.3960/jslrt.54.95

17. Miyata K, Kihira H, Haneda M et al. IgG4-Related Tubulointerstitial Nephritis Associated with Membranous Nephropathy in Two Patients: Remission after Administering a Combination of Steroid and Mizoribine. Case Reports in Nephrology 2014;1–6. doi:10.1155/2014/678538

18. Alexander M, Larsen C, Gibson I et al. Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney International 2013;83(3):455–462. doi: 10.1038/ki.2012.382

19. Ribó M, Hormigos F, Díaz F et al. IgG4-related disease and idiopathic membranous nephropathy: “The clothes do not make the man.” Clinical Nephrology 2016;86(12):345–348. doi: 10.5414/cn108888

20. Khosroshahi A, Ayalon R, Beck L et al. IgG4-Related Disease Is Not Associated with Antibody to the Phospholipase A2 Receptor. International Journal of Rheumatology 2012;1–6. doi: 10.1155/2012/139409

21. Khosroshahi A, Wallace ZS, Crowe JL et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol 2015;67(7):1688–1699. doi: 10.1002/art.39132

22. Okazaki K, Kawa S, Kamisawa T et al. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 I. Concept and diagnosis of autoimmune pancreatitis. Journal of Gastroenterology 2014; 49(4):567–588. doi: 10.1007/s00535-014-0942-2

23. Iguchi T, Takaori K, Mii A et al. Glucocorticoid receptor expression in resident and hematopoietic cells in IgG4-related disease. Mod Pathol 2018;31:890–899. doi: 10.1038/s41379-018-0036-4

24. Saeki T, Kawano M, Mizushima I et al. The clinical course of patients with IgG4-related kidney disease. Kidney Int 2013;84(4):826–833. doi: 10.1038/ki.2013.191

25. Yamada K, Yamamoto M, Saeki T et al. New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases. Arthritis Research & Therapy 2017;19(1). doi: 10.1186/s13075-017-1467-x

26. Betancur-Vásquez L, Gonzalez-Hurtado D, Arango-Isaza D et al. IgG4-Related Disease: Is Rituximab the Best Therapeutic Strategy for Cases Refractory to Conventional Therapy? Results of a Systematic Review. Reumatol Clin 2019;19. pii: S1699-258-X(18)30265-1. doi: 10.1016/j.reuma.2018.11.011

27. Zhang W, Glaze J, Wynne D. Combined membranous nephropathy and tubulointerstitial nephritis as a rare renal manifestation of IgG4-related disease: a case-based literature review. CEN Case Reports 2018;7(1):137–142. doi: 10.1007/s13730-018-0311-8